About Hematide is a novel synthetic Hematide.

About Hematide – is a novel synthetic Hematide, PEGylated peptidic compound that binds to and activates the erythropoietin receptor and thus acts as an erythropoiesis stimulating agent .

In January, Affymax announced the completion of treatment and follow-up of patients enrolled in the four – trial, Phase 3 clinical program for Hematide in the U.S. The company expects to report top-line results from these studies in the second quarter of 2010. And Japan, clinical program enrolled approximately 2,600 patients with chronic renal failure at approximately 400 test centers.Whilst these young are changed in 2003, plurality of have been much better. 1995 and 1997 1995 and 1997 surveys were satisfied about three-quarters of their costs in the health, comparing with current 57 per cent. And the number who are very satisfied by their ability to get the latest treatments, following top specialists and obtained a doctor’s appointment, respectively 17, 15 and 11 items are now lower than in 1995.

Holiday – As mentioned above, much considerable most Americans assess the quality its current care favorably, and the review are substantially unchanged since 2003. Far from perfect far from perfect: While most of the using their own supply, or even coverage costs, far fewer ‘highly ‘satisfied are unhappy.